NEW YORK ( TheStreet) -- Hologic (Nasdaq: HOLX) hit a new 52-week high Thursday as it traded at $21.69 compared with its previous 52-Week high of $21.68. Hologic is changing hands at $21.69 with 105,309 shares traded as of 9:41 a.m. ET. Average volume has been 2.7 million shares over the past 30 days. Hologic has a market cap of $5.5 billion and is part of the health care sector and health services industry. Shares are up 12.2% year to date as of the close of trading on Wednesday. Hologic, Inc. develops, manufactures, and distributes medical imaging systems, and diagnostic and surgical products for serving the healthcare needs of women. The company operates in four segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. TheStreet Ratings rates Hologic as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we find that the growth in the company's net income has been quite unimpressive. You can view the full Hologic Ratings Report. See all 52-week high stocks or get investment ideas from our investment research center.